Skip to main content
. Author manuscript; available in PMC: 2016 Jul 19.
Published in final edited form as: J Neurochem. 2010 May 13;114(3):820–831. doi: 10.1111/j.1471-4159.2010.06807.x

Figure 2.

Figure 2

Labeling pattern obtained from the metabolism of [2-13C]acetyl-L-carnitine via the TCA cycle in rat brain. Labeling pattern from the first and “nth” turns of the cycle are shown. Black circles indicate carbons labeled from metabolism in the first turn of the TCA cycle; grey circles are labeled from metabolism in the second and later turns of the TCA cycle. Open circles are carbons that are not labeled from the metabolism of [2-13C]ALCAR via the TCA cycle. [2-13C]acetyl-L-carnitine is converted to [2-13C]acetyl CoA which condenses with unlabeled oxaloacetate to form labeled citrate which is metabolized via the TCA cycle, giving rise [4-13C]α-ketoglutarate in the first turn. [4-13C]α-ketoglutarate can be converted to [4-13C]glutamate (GLU C4), which can be converted to [2-13C]GABA in GABAergic neurons. In astrocytes, [4-13C]Glutamate can be converted to [4-13C]glutamine by the enzyme glutamine synthetase. [4-13C]α-ketoglutarate can remain in the TCA cycle leading to formation of [3-13C]fumarate, which is a symmetrical molecule so randomization of the label occurs leading to some labeling in the 2 position as well. The same labeling pattern occurs in malate. [3-13C]Oxaloacetate and [2-13C]oxaloacetate formed in the first turn of the TCA cycle can be converted to [3-13C]aspartate (ASP C3) and also [2-13C]aspartate (ASP C2). GLN C3 and GLU C3 are formed after metabolism in the second turn of the cycle, and ASP C2 can also be formed. Abbreviations: GLU, glutamate; GLN, glutamine; MAL, malate; OAA, oxaloacetate.